Transcription factor AP-2 is expressed in human Schwann cell-derived tumours [9]

Histopathology

Volumn 49, Issue 4, 2006, Pages 441-443

  Harder, A ^a   Mautner, V F ^b   Friedrich, R E ^b   Harder, T ^a   Plagemann, A ^a   Von Deimling, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR AP 2;

CELL DENSITY; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MALIGNANT NEURILEMOMA; NEURILEMOMA; NEUROFIBROMA; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

HUMANS; IMMUNOHISTOCHEMISTRY; NERVE SHEATH NEOPLASMS; NEURILEMMOMA; NEUROFIBROMA; TRANSCRIPTION FACTOR AP-2; TUMOR MARKERS, BIOLOGICAL;

EID: 33748750225     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2006.02492.x     Document Type: Letter

References (5)

1. Mitchell PJ, Timmons PM, Hébert JM, Rigby PWJ, Tjian R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 1991; 5; 105-119.
2. Stewart HJS, Brennan A, Rahman M et al. Developmental regulation and overexpression of the transcription factor AP-2, a potential regulator of the timing of Schwann cell generation. Eur. J. Neurosc. 2001; 14; 363-372.
3. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 1996; 13; 1701-1707.
4. Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM, Kosma VM. Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. J. Clin. Oncol. 1998; 16; 3584-3591.
5. Ropponen KM, Kellokoski JK, Pirinen RT et al. Expression of transcription factor AP-2α in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridization. J. Clin. Pathol. 2001; 54; 533-538.